1.Gujjar R, Marwaha A, El Mazouni F, White J, White KL, Creason S, Shackleford DM, Baldwin J, Charman WN, Buckner FS, Charman S, Rathod PK, Phillips MA.. (2009) Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice., 52 (7):[PMID:19296651][10.1021/jm801343r]
2.Gujjar R, El Mazouni F, White KL, White J, Creason S, Shackleford DM, Deng X, Charman WN, Bathurst I, Burrows J, Floyd DM, Matthews D, Buckner FS, Charman SA, Phillips MA, Rathod PK.. (2011) Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice., 54 (11):[PMID:21517059][10.1021/jm200265b]
3.Deng X, Kokkonda S, El Mazouni F, White J, Burrows JN, Kaminsky W, Charman SA, Matthews D, Rathod PK, Phillips MA.. (2014) Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors., 57 (12):[PMID:24801997][10.1021/jm500481t]
4.Singh A, Maqbool M, Mobashir M, Hoda N.. (2017) Dihydroorotate dehydrogenase: A drug target for the development of antimalarials., 125 [PMID:27721149][10.1016/j.ejmech.2016.09.085]
5.Boschi D, Pippione AC, Sainas S, Lolli ML.. (2019) Dihydroorotate dehydrogenase inhibitors in anti-infective drug research., 183 [PMID:31557612][10.1016/j.ejmech.2019.111681]